Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$213K Buy
17,444
+7,316
+72% +$129K ﹤0.01% 2192
2017
Q2
$185K Buy
+10,128
New +$187K ﹤0.01% 2270
2016
Q3
Sell
-59,136
Closed -$1.17M 3156
2016
Q2
$1.17M Buy
59,136
+58,828
+19,100% +$1M 0.02% 1018
2016
Q1
$5K Sell
308
-1,400
-82% -$23.4K ﹤0.01% 3230
2015
Q4
$35K Sell
1,708
-11,316
-87% -$235K ﹤0.01% 3136
2015
Q3
$280K Buy
13,024
+7,476
+135% +$167K ﹤0.01% 2453
2015
Q2
$111K Buy
+5,548
New +$97.4K ﹤0.01% 3048

Other funds holding DXCM

Spot Trading's DXCM Position: Q3 2017 in Review

Spot Trading increased its DexCom (DXCM) stake by 72% in Q3 2017, buying an estimated $129K and bringing the position to 17,444 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

Spot Trading first reported a position in DXCM in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.17M in Q2 2016. 275 funds tracked by Wall St. Rank hold DXCM as of Q3 2017.

  • Spot Trading held 17,444 shares of DexCom worth $213K as of Q3 2017.
  • Spot Trading bought 7,316 DexCom shares in Q3 2017, an estimated $129K.
  • DexCom made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2192 holding.
  • Spot Trading first reported a position in DexCom in Q2 2015 and has held it in 7 quarters since.
  • Spot Trading's DexCom position peaked at $1.17M in Q2 2016.
  • 275 funds tracked by Wall St. Rank held DexCom as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.